Tin tức & Cập nhật
Xem bài viết Tim mạch
Xem

No trade-off between bleeding and ischaemic risk with abbreviated DAPT
Stopping dual antiplatelet therapy (DAPT) after 1 month appeared safe in high-bleeding risk (HBR) patients with acute myocardial infarction (MI) who were implanted with a newer coronary stent, a prespecified subanalysis of the MASTER DAPT* trial has shown.

Bleeding common after acute coronary syndrome
Acute coronary syndrome often leads to bleeding events, particularly at gastrointestinal sites, a recent study has found. Such complications are more likely to occur among older patients and those with hypertension, heart failure, and low baseline haemoglobin levels.

Long-term TAF works against resistant HBV, poses no excess cardiovascular risk
Tenofovir alafenamide (TAF) shows sustained safety and efficacy in heavily pretreated patients with multidrug-resistant hepatitis B virus (HBV) through 3 years of treatment, albeit leading to elevations in cholesterol levels.






